---
document_datetime: 2024-10-14 11:12:36
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/kapruvia-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: kapruvia-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 1.7769908
conversion_datetime: 2026-01-10 11:00:30.437614
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.1
  docling: 2.67.0
  docling-core: 2.58.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Kapruvia

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                          | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                           |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------------------------------|
| IB/0008              | C.I.3.z - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Other variation | 25/07/2024                          |                                             | SmPC                             |                                   |
| PSUSA/10995          | Periodic Safety Update EU Single assessment -                                                                                                                                                  | 07/03/2024                          | n/a                                         |                                  | PRAC Recommendation - maintenance |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| /202308             | difelikefalin                                                                                                                                                                                                                                |            |            |                                  |                                                                                                            |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------------------------------------------------------------------------------------------------------------|
| IA/0006             | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient | 27/02/2024 | n/a        |                                  |                                                                                                            |
| PSUSA/10995 /202302 | Periodic Safety Update EU Single assessment - difelikefalin                                                                                                                                                                                  | 28/09/2023 | n/a        |                                  | PRAC Recommendation - maintenance                                                                          |
| PSUSA/10995 /202208 | Periodic Safety Update EU Single assessment - difelikefalin                                                                                                                                                                                  | 16/03/2023 | n/a        |                                  | PRAC Recommendation - maintenance                                                                          |
| IB/0002             | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                | 21/09/2022 | n/a        |                                  |                                                                                                            |
| IB/0001             | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                               | 22/07/2022 | 17/07/2023 | SmPC, Annex II, Labelling and PL | To implement editorial changes in sections 4.8, 5.1 and 5.2 of the SmPC, annex II and section 3 of the PL. |